Medicamen Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

83.17

66.62

55.39

60.05

56.89

Operating profit

13.56

11.51

11.29

12.27

9.45

Interest

1.86

1.38

1.06

0.34

0.62

Gross profit

12.63

11.62

11.40

12.48

9.04

EPS (Rs)

5.87

5.69

5.35

6.85

4.36

Other income

0.93

1.49

1.17

0.56

0.22

Stock adjustment

-9.76

-3.01

-2.21

-1.12

0.46

Raw material

53.33

36.47

28.43

27.26

35.67

Power and fuel

-

-

-

-

-

Employee expenses

10.47

9.25

7.46

7.04

4.33

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

15.57

12.39

10.43

14.61

6.99

Provisions made

-

-

-

-

-

Depreciation

3.48

3.14

3.09

2.68

1.39

Taxation

1.73

1.28

1.77

1.43

2.32

Net profit / loss

7.43

7.20

6.53

8.37

5.33

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

12.65

12.65

12.22

12.22

12.22

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

16.31

17.28

20.38

20.43

16.60

GPM (%)

15.02

17.06

20.15

20.59

15.84

NPM (%)

8.83

10.57

11.55

13.82

9.33